Ironwood Pharmaceuticals: Q3 Earnings Insights

Ironwood Pharmaceuticals IRWD reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Ironwood Pharmaceuticals beat estimated earnings by 7.69%, reporting an EPS of $0.28 versus an estimate of $0.26.

Revenue was up $4.89 million from the same period last year.

Last quarter the company missed on EPS by $0.09 which was followed by a 3.4% increase in the share price the next day.

Here's a look at Ironwood Pharmaceuticals's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	0.30	0.25	0.35	0.31
EPS Actual	0.21	0.21	0.27	0.33
Revenue Estimate	103.51M	94.35M	109.87M	105.40M
Revenue Actual	97.23M	97.53M	117.13M	103.75M

To track all earnings releases for Ironwood Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar